No Data
No Data
No Data
No Data
No Data
Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option
WOBURN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB:CMRA) ("Comera" or the "Company"), a life sciences company developing a proprietary drug-delivery technology to improve
GlobeNewswireJan 4 08:30 ET
Comera Life Sciences Announces Process Exploring Strategic Alternatives
WOBURN, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (OTCQB:CMRA) ("Comera" or the "Company"), a life sciences company developing a new generation of biologic medicines to improve
GlobeNewswireDec 6, 2023 08:30 ET
Comera Life Sciences(CMRA.US) Officer Buys US$708 in Common Stocks
$Comera Life Sciences(CMRA.US)$ Officer Campbell Michael Gerard purchased 10,000 shares of Common Stocks on Nov 27, 2023 at an average price of $0.0708 for a total value of $708.Source: Announcement W
moomoo NewsNov 28, 2023 17:05 ET
Comera Life Sciences Designates Dorothy Clarke to Board of Directors
Yahoo FinanceNov 13, 2023 19:59 ET
Comera Life Sciences Appoints Dorothy Clarke to Board of Directors
Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) today announced it appointed Dorothy Clarke to its board of directors.
GlobeNewswireNov 13, 2023 08:00 ET
Comera Life Sciences Q3 EPS $(0.10) Up From $(0.20) YoY, Sales $136.31K Down From $234.92K YoY
Comera Life Sciences (NASDAQ:CMRA) reported quarterly losses of $(0.10) per share. This is a 50 percent increase over losses of $(0.20) per share from the same period last year. The company reported
BenzingaNov 9, 2023 08:18 ET
No Data
No Data